Updates
** Hospital operator HCA Healthcare's HCA.N shares fall 5.4% to $322.7
** HCA beat Q1 profit estimates and reiterates 2025 profit forecast as the hospital operator benefited from sustained demand for elective procedures in the United States
** "Company is unclear about the effects of federal policy changes on its business," says CEO Samuel Hazen
** "Company could not give specifics on potential tariff effects, and the market appears to be reacting negatively to that uncertainty despite the strong results that HCA delivered in early 2025," says Morningstar analyst Julie Utterback
** HCA posts Q1 profit of $6.45/share, above analysts' estimate of $5.76/share, according to data compiled by LSEG
** Co maintains its annual profit forecast in range of $24.05-$25.85/share vs est. of $24.92/share
** As of last close, HCA up 13.8% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。